Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $5.1800 (-4.69%) ($5.1800 - $5.1800) on Tue. Dec. 28, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.95% (three month average) | RSI | 33 | Latest Price | $5.1800(-4.69%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -0.6% a day on average for past five trading days. | Weekly Trend | AUTL declines -9.5% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) XBI(65%) IBB(60%) IBUY(58%) ARKG(56%) ARKK(55%) | Factors Impacting AUTL price | AUTL will decline at least -2.475% in a week (0% probabilities). VIXM(-39%) VXX(-32%) TLT(-25%) SHY(-22%) TIP(-19%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.475% (StdDev 4.95%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-10.86(-309.65%) | Resistance Level | $5.85 | 5 Day Moving Average | $5.34(-3%) | 10 Day Moving Average | $5.42(-4.43%) | 20 Day Moving Average | $5.85(-11.45%) | To recent high | -26.5% | To recent low | 0% | Market Cap | $271m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |